CMPX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 30.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Compass Therapeutics Insider Trading History Chart

Compass Therapeutics Share Price & Price History

^$1.53

▼ -0.04 (-2.55%)

As of 04/17/2024 01:00 AM ET

Days: 30 | 90 | 365

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Compass Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/10/2023	Thomas J Schuetz	CEO	Buy	10,000	$3.37	$33,700.00	6,021,873
2/27/2023	Thomas J Schuetz	CEO	Buy	20,000	$3.98	$79,600.00	6,011,873
2/15/2023	Thomas J Schuetz	CEO	Buy	20,000	$3.86	$77,200.00	5,991,873
1/31/2023	Thomas J Schuetz	CEO	Buy	20,000	$4.05	$81,000.00	5,471,873
1/24/2023	Thomas J Schuetz	CEO	Buy	20,000	$4.19	$83,800.00	5,451,873
11/25/2022	Vered Bisker-Leib	COO	Sell	2	$4.36	$8.72	1,060,414
11/22/2022	Vered Bisker-Leib	COO	Sell	14,929	$4.19	$62,552.51	1,069,985
11/8/2022	Orbimed Advisors Llc	Director	Buy	402,000	$3.21	$1,290,420.00	15,219,994
9/28/2022	Thomas J Schuetz	CEO	Buy	10,000	$2.32	$23,200.00	5,431,873
9/26/2022	Thomas J Schuetz	CEO	Buy	15,000	$2.27	$34,050.00	5,421,873
8/10/2022	Thomas J Schuetz	CEO	Buy	15,000	$2.64	$39,600.00	5,361,873
8/1/2022	Thomas J Schuetz	CEO	Buy	15,000	$2.58	$38,700.00	5,346,873
6/21/2022	Thomas J Schuetz	CEO	Buy	20,000	$2.80	$56,000.00	5,331,873
6/16/2022	Thomas J Schuetz	CEO	Buy	20,000	$2.34	$46,800.00	5,311,873
6/13/2022	Thomas J Schuetz	CEO	Buy	30,000	$2.29	$68,700.00	5,291,873
6/6/2022	Thomas J Schuetz	CEO	Buy	30,000	$2.83	$84,900.00	5,261,873
6/1/2022	Thomas J Schuetz	CEO	Buy	20,000	$3.03	$60,600.00	5,231,873
5/26/2022	Thomas J Schuetz	CEO	Buy	20,000	$3.04	$60,800.00	5,211,873
5/23/2022	Thomas J Schuetz	CEO	Buy	18,355	$2.72	$49,925.60	5,191,873
5/13/2022	Carl L Gordon	Director	Buy	30,722	$2.49	$76,497.78	14,817,994
5/11/2022	Carl L Gordon	Director	Buy	64,700	$1.79	$115,813.00	14,690,178
5/10/2022	Thomas J Schuetz	CEO	Buy	27,836	$1.80	$50,104.80	5,153,303
5/9/2022	Orbimed Advisors Llc	Director	Buy	90,712	$1.56	$141,510.72	14,601,031
5/6/2022	Orbimed Advisors Llc	Director	Buy	10,200	$1.63	$16,626.00	14,510,319
11/4/2021	Carl L Gordon	Director	Buy	5,357,143	$3.50	$18,750,000.50

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for Compass Therapeutics (NASDAQ:CMPX)

68.43% of Compass Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Compass Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	4,081,189	$6.37M	0.0%	-0.6%	3.201%
3/1/2024	Goldman Sachs Group Inc.	206,597	$0.32M	0.0%	-6.2%	0.162%
2/26/2024	Virtu Financial LLC	28,054	$44K	0.0%	N/A	0.022%
2/15/2024	Blue Owl Capital Holdings LP	2,829,712	$4.41M	0.8%	N/A	2.220%
2/15/2024	Legal & General Group Plc	21,548	$34K	0.0%	-54.0%	0.017%
2/15/2024	Barclays PLC	125,486	$0.20M	0.0%	+314.1%	0.098%
2/15/2024	Vanguard Group Inc.	4,081,189	$6.37M	0.0%	-0.6%	3.201%
2/15/2024	Nuveen Asset Management LLC	304,504	$0.48M	0.0%	-23.4%	0.239%
2/15/2024	Citadel Advisors LLC	166,137	$0.26M	0.0%	N/A	0.130%
2/14/2024	Braidwell LP	317,761	$0.50M	0.0%	-94.7%	0.249%
2/14/2024	Pennant Investors LP	199,000	$0.31M	0.1%	N/A	0.156%
2/14/2024	Pale Fire Capital SE	181,055	$0.28M	0.0%	+301.0%	0.142%
2/13/2024	Northern Trust Corp	759,733	$1.19M	0.0%	-7.9%	0.596%
2/13/2024	Goldman Sachs Group Inc.	206,597	$0.32M	0.0%	-6.2%	0.162%
2/12/2024	Monashee Investment Management LLC	500,000	$0.78M	0.1%	-59.2%	0.392%
2/12/2024	Hsbc Holdings PLC	32,145	$48K	0.0%	N/A	0.025%
2/9/2024	Element Capital Management LLC	293,888	$0.46M	1.6%	N/A	0.231%
2/6/2024	Charles Schwab Investment Management Inc.	246,012	$0.38M	0.0%	-6.6%	0.193%
1/12/2024	SG Americas Securities LLC	47,624	$74K	0.0%	+22.7%	0.037%
1/5/2024	Exchange Traded Concepts LLC	65,819	$0.10M	0.0%	+34.0%	0.052%
12/18/2023	Vanguard Group Inc.	4,107,519	$8.09M	0.0%	+0.2%	3.222%
12/1/2023	B. Riley Wealth Advisors Inc.	50,000	$98K	0.0%	+235.2%	0.039%
11/24/2023	Deutsche Bank AG	44,614	$88K	0.0%	+21.8%	0.035%
11/15/2023	Legal & General Group Plc	46,872	$92K	0.0%	-29.5%	0.037%
11/15/2023	Adage Capital Partners GP L.L.C.	6,380,000	$12.57M	0.0%	+2.1%	5.004%
11/14/2023	Blackstone Inc.	6,189,551	$12.19M	0.1%	+3.1%	4.855%
11/14/2023	Avidity Partners Management LP	1,599,600	$3.15M	0.1%	-1.3%	1.255%
11/14/2023	California State Teachers Retirement System	87,289	$0.17M	0.0%	-10.1%	0.068%
11/14/2023	Monashee Investment Management LLC	1,226,142	$2.42M	1.0%	-37.7%	0.962%
11/14/2023	Pale Fire Capital SE	45,155	$89K	0.0%	N/A	0.035%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	132,792	$0.26M	0.0%	+15.4%	0.104%
11/13/2023	Algert Global LLC	33,963	$67K	0.0%	-61.8%	0.027%
11/13/2023	Northern Trust Corp	825,114	$1.63M	0.0%	+7.2%	0.647%
11/13/2023	Foresite Capital Management V LLC	1,246,977	$2.46M	3.9%	-5.8%	0.978%
11/13/2023	Invesco Ltd.	66,096	$0.13M	0.0%	+71.0%	0.052%
11/13/2023	FMR LLC	4,553,093	$8.97M	0.0%	-17.7%	3.571%
11/9/2023	Deutsche Bank AG	44,614	$88K	0.0%	+21.8%	0.035%
11/8/2023	Charles Schwab Investment Management Inc.	263,276	$0.52M	0.0%	+4.7%	0.207%
10/18/2023	Exchange Traded Concepts LLC	49,129	$97K	0.0%	+13.7%	0.039%
10/13/2023	SG Americas Securities LLC	38,807	$76K	0.0%	N/A	0.030%
10/12/2023	New Capital Management LP	24,243	$48K	0.0%	N/A	0.019%
9/21/2023	Barclays PLC	31,921	$0.10M	0.0%	-22.1%	0.025%
8/21/2023	California State Teachers Retirement System	97,124	$0.31M	0.0%	+46.3%	0.076%
8/15/2023	Alliancebernstein L.P.	11,260	$36K	0.0%	N/A	0.009%
8/15/2023	Wells Fargo & Company MN	35,120	$0.11M	0.0%	+2,526.8%	0.028%
8/15/2023	XTX Topco Ltd	10,992	$35K	0.0%	N/A	0.009%
8/15/2023	Goldman Sachs Group Inc.	107,556	$0.34M	0.0%	-45.8%	0.084%
8/15/2023	Royal Bank of Canada	12,750	$41K	0.0%	+1,232.3%	0.010%
8/15/2023	Stifel Financial Corp	15,000	$48K	0.0%	N/A	0.012%
8/15/2023	Braidwell LP	5,954,273	$18.94M	0.6%	+83.3%	4.671%
8/15/2023	Caxton Corp	43,466	$0.14M	0.4%	-79.5%	0.034%
8/14/2023	State of Wisconsin Investment Board	11,601	$35K	0.0%	-83.4%	0.009%
8/14/2023	State Street Corp	1,746,514	$5.55M	0.0%	+334.1%	1.370%
8/14/2023	Nuveen Asset Management LLC	391,871	$1.25M	0.0%	N/A	0.307%
8/14/2023	Prosight Management LP	1,083,997	$3.45M	1.1%	+59.8%	0.850%
8/11/2023	Credit Suisse AG	77,424	$0.25M	0.0%	+33.1%	0.061%
8/11/2023	BlackRock Inc.	6,032,292	$19.18M	0.0%	+291.5%	4.733%
8/11/2023	State Board of Administration of Florida Retirement System	25,910	$77K	0.0%	N/A	0.020%
8/11/2023	The Manufacturers Life Insurance Company	37,520	$0.12M	0.0%	N/A	0.029%
8/11/2023	Geode Capital Management LLC	1,808,207	$5.75M	0.0%	+104.6%	1.419%
8/11/2023	Foresite Capital Management V LLC	1,324,071	$4.21M	3.1%	-62.0%	1.039%
8/11/2023	JPMorgan Chase & Co.	71,164	$0.23M	0.0%	+17,385.0%	0.056%
8/11/2023	Northern Trust Corp	769,865	$2.45M	0.0%	+315.5%	0.604%
8/10/2023	MetLife Investment Management LLC	49,953	$0.16M	0.0%	N/A	0.039%
8/10/2023	Monashee Investment Management LLC	1,969,296	$6.26M	1.5%	-9.5%	1.545%
8/10/2023	ProShare Advisors LLC	11,868	$38K	0.0%	N/A	0.009%
8/10/2023	Charles Schwab Investment Management Inc.	251,396	$0.80M	0.0%	+487.8%	0.197%
8/10/2023	Citigroup Inc.	29,088	$92K	0.0%	-79.7%	0.023%
8/4/2023	American International Group Inc.	43,924	$0.14M	0.0%	N/A	0.035%
8/3/2023	Barclays PLC	31,921	$0.10M	0.0%	-22.1%	0.025%
8/3/2023	Bank of New York Mellon Corp	271,296	$0.86M	0.0%	+590.2%	0.214%
7/31/2023	Strs Ohio	19,000	$60K	0.0%	N/A	0.015%
7/20/2023	Exchange Traded Concepts LLC	43,205	$0.14M	0.0%	N/A	0.034%
5/16/2023	Susquehanna International Group LLP	782,617	$2.56M	0.0%	+71.7%	0.619%
5/16/2023	Jane Street Group LLC	382,385	$1.25M	0.0%	+508.6%	0.302%
5/16/2023	State Street Corp	402,313	$1.32M	0.0%	+48.9%	0.318%
5/16/2023	Squarepoint Ops LLC	16,263	$53K	0.0%	N/A	0.013%
5/16/2023	Fred Alger Management LLC	403,062	$1.32M	0.0%	-33.8%	0.319%
5/16/2023	Geode Capital Management LLC	883,563	$2.89M	0.0%	+11.8%	0.698%
5/15/2023	Schonfeld Strategic Advisors LLC	14,127	$46K	0.0%	N/A	0.011%
5/15/2023	Cubist Systematic Strategies LLC	51,576	$0.17M	0.0%	+400.7%	0.041%
5/15/2023	Braidwell LP	3,247,847	$10.62M	0.4%	+79.0%	2.567%
5/15/2023	Two Sigma Investments LP	15,222	$50K	0.0%	N/A	0.012%
5/15/2023	Boothbay Fund Management LLC	26,945	$88K	0.0%	+57.3%	0.021%
5/12/2023	Prosight Management LP	678,300	$2.22M	1.1%	N/A	0.536%
5/12/2023	BlackRock Inc.	1,540,895	$5.04M	0.0%	+24.5%	1.218%
5/12/2023	Bank of America Corp DE	93,980	$0.31M	0.0%	+114,509.8%	0.074%
5/12/2023	UBS Group AG	7,682	$25K	0.0%	-35.0%	0.006%
5/12/2023	Foresite Capital Management V LLC	3,480,723	$11.38M	8.4%	-20.9%	2.751%
5/11/2023	FMR LLC	5,681,072	$18.58M	0.0%	-10.6%	4.491%
5/11/2023	ExodusPoint Capital Management LP	16,840	$55K	0.0%	N/A	0.013%
5/11/2023	Citigroup Inc.	142,941	$0.47M	0.0%	+13.2%	0.113%
5/10/2023	Credit Suisse AG	58,159	$0.19M	0.0%	N/A	0.046%
5/10/2023	Swiss National Bank	163,400	$0.53M	0.0%	N/A	0.129%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	22,551	$74K	0.0%	N/A	0.018%
5/9/2023	Tower Research Capital LLC TRC	7,855	$26K	0.0%	+577.2%	0.006%
5/9/2023	Wedbush Securities Inc.	43,444	$0.14M	0.0%	N/A	0.034%
5/9/2023	California State Teachers Retirement System	66,392	$0.22M	0.0%	N/A	0.052%
5/5/2023	Monashee Investment Management LLC	2,177,042	$7.12M	2.0%	-2.4%	1.721%
5/4/2023	Barclays PLC	40,986	$0.13M	0.0%	+124.9%	0.032%

Data available starting January 2016

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $1.53

$1.50

$1.65

50 Day Range

MA: $1.85

$1.45

$2.29

52 Week Range

Now: $1.53

$1.15

$3.62

Volume

120,088 shs

Average Volume

494,862 shs

Market Capitalization

$210.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.78

Who are the company insiders with the largest holdings of Compass Therapeutics?: Compass Therapeutics' top insider investors include:
Orbimed Advisors Llc (Director)
Carl L Gordon (Director)
Thomas J Schuetz (CEO)
Vered Bisker-Leib (COO)
Learn More about top insider investors at Compass Therapeutics.